{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:19:43Z","timestamp":1715969983852},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"DOI":"10.1093\/jac\/dkl551","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T03:59:21Z","timestamp":1172807961000},"page":"827-832","source":"Crossref","is-referenced-by-count":24,"title":["Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil"],"prefix":"10.1093","volume":"59","author":[{"suffix":"IV","given":"William E.","family":"Delaney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,3,1]]},"reference":[{"key":"key\n\t\t\t\t20171010154852_DKL551C1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171010154852_DKL551C2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa021812","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B","volume":"348","author":"Hadziyannis","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171010154852_DKL551C3","first-page":"581A","article-title":"Long-term experience of adefovir dipivoxil add-on therapy in chronic hepatitis B patients co-infected with HIV and lamivudine-resistant HBV: absence of adefovir resistance mutation selection","volume":"42","author":"Thibault","year":"2005","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171010154852_DKL551C4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-8278(05)81485-0","article-title":"Increasing serologic, virologic and biochemical response over time to adefovir dipivoxil (ADV) 10\u00a0mg in HBeAg+ chronic hepatitis B (CHB) patients","volume":"42","author":"Marcellin","year":"2005","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171010154852_DKL551C5","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S1386-6532(06)80286-6","article-title":"Durability of HBeAg seroconversion following adefovir dipivoxil treatment for chronic hepatitis B","volume":"36","author":"Chang","year":"2006","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20171010154852_DKL551C6","article-title":"Long-term treatment with adefovir dipivoxil (10\u00a0mg) in patients with lamivudine-resistant (LAM-R) HBV and HIV co-infection results in significant and sustained clinical improvement","author":"Benhamou"},{"key":"key\n\t\t\t\t20171010154852_DKL551C7","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.282.24.2305","article-title":"Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial","volume":"282","author":"Kahn","year":"1999","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171010154852_DKL551C8","doi-asserted-by":"crossref","DOI":"10.1002\/lt.20981","article-title":"Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results","author":"Schiff","year":"2007","journal-title":"Liver Transpl"},{"key":"key\n\t\t\t\t20171010154852_DKL551C9","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1016\/j.transproceed.2005.10.061","article-title":"Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus","volume":"37","author":"Barcena","year":"2005","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t20171010154852_DKL551C10","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.tp.0000178305.39231.a2","article-title":"Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency","volume":"80","author":"Fontaine","year":"2005","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20171010154852_DKL551C11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/ndt\/gfg505","article-title":"The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV","volume":"19","author":"Hannon","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20171010154852_DKL551C12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0016-5085(03)00939-9","article-title":"Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase","volume":"125","author":"Angus","year":"2003","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171010154852_DKL551C13","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","author":"Lok","year":"2003","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171010154852_DKL551C14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0168-8278(05)81448-5","article-title":"Incidence and predictors of emergence of adefovir resistant HBV during four years of adefovir dipivoxil (ADV) therapy for patients with chronic hepatitis B (CHB)","volume":"42","author":"Locarnini","year":"2005","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171010154852_DKL551C15","first-page":"639A","article-title":"Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B","volume":"44","author":"Lampertico","year":"2006","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171010154852_DKL551C16","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.00138-06","article-title":"Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus","volume":"50","author":"Delaney","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171010154852_DKL551C17","doi-asserted-by":"crossref","DOI":"10.1177\/135965350701200309","article-title":"In vitro susceptibility of adefovir-associated hepatitis B virus mutations to other antiviral agents","author":"Qi","year":"2007","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20171010154852_DKL551C18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0168-8278(04)90383-2","article-title":"In vitro characterization and molecular modeling analysis of a novel adefovir resistance mutation rtN236T in the HBV polymerase","volume":"40","author":"Yang","year":"2004","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171010154852_DKL551C19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0168-8278(05)81947-6","article-title":"In vitro cross-resistance analysis of the HBV polymerase mutation A181V","volume":"42","author":"Qi","year":"2005","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171010154852_DKL551C20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1053\/jhep.2000.7296","article-title":"Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy","volume":"31","author":"Yeh","year":"2000","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171010154852_DKL551C21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jhep.2003.09.022","article-title":"Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient","volume":"39","author":"Villeneuve","year":"2003","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171010154852_DKL551C22","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2005.09.003","article-title":"Resistance to adefovir: a new challenge in the treatment of chronic hepatitis B","volume":"43","author":"Marcellin","year":"2005","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171010154852_DKL551C23","first-page":"588A","article-title":"Efficacy of tenofovir in patients with chronic hepatitis B and resistance or sub-optimal response to adefovir","volume":"42","author":"Villeneuve","year":"2005","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171010154852_DKL551C24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-5926-5-1","article-title":"Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant","volume":"5","author":"Ratziu","year":"2006","journal-title":"Comp Hepatol"},{"key":"key\n\t\t\t\t20171010154852_DKL551C25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0168-8278(04)90057-8","article-title":"Long-term incidence of adefovir dipivoxil (ADV) resistance in chronic hepatitis B (CHB) patients after 144 weeks of therapy","volume":"40","author":"Qi","year":"2004","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171010154852_DKL551C26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2005.10.018","article-title":"Virologic response and resistance to adefovir in patients with chronic hepatitis B","volume":"44","author":"Fung","year":"2006","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171010154852_DKL551C27","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","article-title":"Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine","volume":"48","author":"Tenney","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171010154852_DKL551C28","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa042957","article-title":"Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B","volume":"352","author":"Hadziyannis","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171010154852_DKL551C29","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years","volume":"131","author":"Hadziyannis","year":"2006","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171010154852_DKL551C30","first-page":"1419","article-title":"Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients","volume":"38","author":"Schiff","year":"2003","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171010154852_DKL551C31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2893.2005.00578.x","article-title":"Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients","volume":"12","author":"Westland","year":"2005","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20171010154852_DKL551C32","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0140-6736(01)05840-8","article-title":"Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study","volume":"358","author":"Benhamou","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171010154852_DKL551C33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jhep.2005.08.020","article-title":"Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1","volume":"44","author":"Benhamou","year":"2006","journal-title":"J Hepatol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/59\/5\/827\/2161009\/dkl551.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T20:44:21Z","timestamp":1683751461000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/59\/5\/827\/727527\/Progress-in-the-treatment-of-chronic-hepatitis-B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,1]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,3,1]]},"published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkl551","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,5]]},"published":{"date-parts":[[2007,3,1]]}}}